Oral News and Research

RSS

International Microbicides Conference 2012 concludes

The conclusion of the 2012 International Microbicides Conference, a gathering of researchers, advocates and funders in the HIV prevention field, wrapped up three days of discussion focused on access to prevention technologies, adherence in clinical trials, innovative financing, dual prevention technologies and new methods of preventing rectal transmission of HIV.

26 Apr 2012

First-ever study to evaluate effects of interaction between metamphetamines and Ibudilast

John W. Tsuang, M.D., principal investigator at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), in conjunction with Steven J. Shoptaw, Ph.D., from the UCLA Department of Family Medicine, is spearheading a Phase I clinical safety trial that for the first time examines the effects of Ibudilast when administered with metamphetamine (MA), an addictive stimulant that is closely related to amphetamine.

26 Apr 2012

Case study in the Journal of AAPOS highlights need for vigilance

It has been estimated that roughly 4% to 6% of child abuse victims present first to an ophthalmologist. In a case study in the April issue of the Journal of American Association of Pediatric Ophthalmology and Strabismus, doctors at the University of Washington and the Seattle Children's Hospital describe a case of a 13-month-old girl who was initially diagnosed with corneal abrasion and a mild infection. She was eventually identified as a victim of child abuse.

26 Apr 2012

Pig mucus effective at blocking viruses associated with cervical and oral cancer

Scientists are reporting that the mucus lining the stomachs of pigs could be a long-sought, abundant source of "mucins" being considered for use as broad-spectrum anti-viral agents to supplement baby formula and for use in personal hygiene and other consumer products to protect against a range of viral infections. Their study appears in ACS' journal Biomacromolecules.

26 Apr 2012

Survey: After Supreme Court arguments, public still divided on health law

The Kaiser Family Foundation's tracking poll found that the oral arguments held last month before the high court raised awareness about the health law, but didn't sway public opinion.

25 Apr 2012

Biogen Idec announces positive data from oral BG-12 second Phase 3 trial on RRMS

Today Biogen Idec announced that detailed positive data from CONFIRM, the second Phase 3 clinical trial of oral BG-12 (dimethyl fumarate) in people with relapsing-remitting multiple sclerosis (RRMS), will be presented in three platform presentations at the 64th Annual Meeting of the American Academy of Neurology (AAN) in New Orleans.

25 Apr 2012

Collective bargaining agreements mean public employee benefit changes in Conn., Wis.

Collective bargaining agreements are changing health plans in Connecticut and Wisconsin for home care workers, teachers and a police union -- which, if it was not granted an injunction from a judge, would have had to pay new deductibles and copays in Milwaukee.

24 Apr 2012

IADR/AADR publish two studies about dental caries in children

The International and American Associations for Dental Research have published two studies about dental caries in children. These articles, titled "Hypoplasia-Associated Severe Early Childhood Caries - A Proposed Definition" and "Deciduous Molar Hypomineralization and Molar Incisor Hypomineralization" discuss the definitions of dental caries susceptibility to the hypomineralization and hypoplasia.

24 Apr 2012

State roundup: Mo. bill would outlaw federal health law; Texas docs got unwarranted Medicare bonuses

The Missouri House thinks the dreaded federal health care reform law is a crime. Or at least a misdemeanor. Going even further than other state legislatures fighting the law, the Missouri state House has passed a bill declaring the Affordable Care Act unconstitutional and therefore "altogether void and of no force." Any federal worker who tries to implement it would be committing a misdemeanor.

24 Apr 2012

Medgenics seeks FDA Orphan Drug Designation for INFRADURE to treat hepatitis D

Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed for Orphan Drug Designation with the U.S. Food and Drug Administration (FDA) for INFRADURE for the treatment of hepatitis D.

23 Apr 2012

MicuRx completes MRX-I Phase 1 trial on MRSA and VRE infection

MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced the completion of its Phase 1 clinical trial for MRX-I, its first development-stage antibiotic drug candidate.

23 Apr 2012

Gum disease and heart problems not linked: Review

It has been claimed for the past few decades that gum disease is linked to heart problems or strokes but according to latest findings the link does not hold up on deeper research says the American Heart Association.

22 Apr 2012

LCIG improves quality of life, reduces symptoms of Parkinson's

A recent clinical trial conducted at Evergreen Healthcare shows that a new form of a common drug used to treat Parkinson's Disease greatly improves the quality of life for patients and reduces the affects of symptoms such as tremors, slowness, stiffness and difficulty walking.

21 Apr 2012

AADR acknowledges review that examines link between ASVD and periodontal disease

Today, the American Association for Dental Research (AADR) acknowledged the very comprehensive review of the literature undertaken by the American Heart Association (AHA) on the relationship between periodontal disease and heart disease.

21 Apr 2012

Orthopaedic research studies in the Journal of Bone and Joint Surgery

Below are highlights of orthopaedic research studies appearing in the April 18th issue of the Journal of Bone and Joint Surgery (JBJS), as well as the issue's full Table of Contents.

21 Apr 2012

Results from Boehringer Ingelheim's afatinib Phase III lung cancer trial

Highly anticipated results from LUX-Lung 3, the pivotal Phase III lung cancer trial investigating Boehringer Ingelheim's front running oncology investigational compound, the ErbB Family Blocker afatinib, in patients with EGFR mutations, will be presented at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from 1 - 5 June 2012.

21 Apr 2012

Updated results from CircuLite’s Synergy miniature ventricular support system clinical study

CircuLite, Inc. today announced that updated clinical data related to the Synergy miniature ventricular support system was presented in two oral presentations and one poster session at the International Society for Heart and Lung Transplantation's 32nd Annual Meeting and Scientific Sessions (ISHLT) in Prague, Czech Republic.

21 Apr 2012

Sequana Medical's ALFApump System safe and effective in managing ascites

Sequana Medical announced that initial results from the PIONEER Clinical Study of its ALFApump System were presented today at the 47th annual European Association for Study of the Liver Meeting in Barcelona.

21 Apr 2012

New data from descriptive sub-analysis of patients with compensated liver cirrhosis

New data from a descriptive sub-analysis of patients with compensated liver cirrhosis show that up to 43 percent of genotype-1a (GT1a) and up to 71 percent of GT1b hepatitis C virus (HCV) patients achieved sustained viral response (SVR12). SVR12 has been highly correlated with SVR24, which is a recognized indicator of viral cure.

20 Apr 2012

New data provides hope for HCV non-responders

New data from a number of clinical trials presented for the first time at the International Liver Congress- 2012 provides hope for previously difficult to treat hepatitis C (HCV) patient populations.

20 Apr 2012

Oral News and Research

International Microbicides Conference 2012 concludes

First-ever study to evaluate effects of interaction between metamphetamines and Ibudilast

Case study in the Journal of AAPOS highlights need for vigilance

Pig mucus effective at blocking viruses associated with cervical and oral cancer

Survey: After Supreme Court arguments, public still divided on health law

Biogen Idec announces positive data from oral BG-12 second Phase 3 trial on RRMS

Collective bargaining agreements mean public employee benefit changes in Conn., Wis.

IADR/AADR publish two studies about dental caries in children

State roundup: Mo. bill would outlaw federal health law; Texas docs got unwarranted Medicare bonuses

Medgenics seeks FDA Orphan Drug Designation for INFRADURE to treat hepatitis D

MicuRx completes MRX-I Phase 1 trial on MRSA and VRE infection

Gum disease and heart problems not linked: Review

LCIG improves quality of life, reduces symptoms of Parkinson's

AADR acknowledges review that examines link between ASVD and periodontal disease

Orthopaedic research studies in the Journal of Bone and Joint Surgery

Results from Boehringer Ingelheim's afatinib Phase III lung cancer trial

Updated results from CircuLite’s Synergy miniature ventricular support system clinical study

Sequana Medical's ALFApump System safe and effective in managing ascites

New data from descriptive sub-analysis of patients with compensated liver cirrhosis

New data provides hope for HCV non-responders

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News